TMCnet News
Research and Markets: Global Gene Therapy Market & Pipeline Insight Report 2014 - Analysis of 315 Drug therapy Pipelines for the $500 Million MarketDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/z3msbh/global_gene) has announced the addition of the "Global Gene Therapy Market & Pipeline Insight" report to their offering. The global market opportunity for gene therapy is expected to reach USD 500 million by 2020 There have been significant advancements in the area of gene therapy in terms of research of new drugs. Over the past 20 years, the gene therapy market has witnessed significant advances ranging from the stage of conception, to the current stage of clinical trials for various disease conditions. When compared to other conventional methods such as radiotherapy and chemotherapy, gene therapy enjoys a clear advantage mainly because this therapy does not inhibit the immune system. Also, there has been an increased use of innovative technologies, which has led to an expansion of the scope of gene therapy worldwide. The growth of this market greatly depends on the regulatory approval of products which are currently in clinical trials. A major part of the gene therapy products for cancer and cardiovascular diseases are currently in Phase II and Phase III of clinical trials. Other factors impacting the gene therapy market are the cost of the treatment and th disease population under study. Additionally, funding and developments in research coupled with acceptance of gene therapy products to use in medicine are also expected to impact the market in the near future. Although the initial studies of gene therapy were conducted mostly on monogenetic diseases, the focus of the scientists rapidly shifted towards cancer. This increasing popularity of cancer therapeutics as a major interest for gene therapy applications led to it accounting for dominant share in the overall clinical trials being conducted. The major reasons for cancer to become a preferred area of application for gene therapy are the significant unmet medical needs in cancer therapy, coupled with the large size of its market. Additionally, the ethical acceptance of gene therapy as a therapeutic solution also contributed to the shift of focus from monogenetic diseases to cancer. Global Gene Therapy Market & Pipeline Insight Market Highlight:
Key Topics Covered: 1. Introduction to Gene Therapy 2. Gene Therapy Classification 3. Mechanism of Gene Therapy 4. Global Gene Therapy Market Overview 5. Significance of Gene Therapy in Cancer Therapeutics 6. Current Applications of Gene Therapy to Cancer Treatment 7. Global Gene Therapy Market Dynamics 8. Gene Therapy Market Future Growth Outlook 9. EMA (News - Alert) Guidelines for Gene Therapy 10. FDA Guidelines for Gene Therapy 11. Gene Therapy Pipeline by Phase, Indications, Country & Company 12. Marketed Gene Therapies by Indications, Country & Company 13. Suspended & Discontinued Gene Therapy in Pipeline 14. Competitive Landscape - Advantagene - BioCancell - Celgene - Epeius Biotechnologies - GenVec - Genethon - Introgen Therapeutics - MultiVir - Shenzhen SiBiono GeneTech - Vical - ZIOPHARM Oncology For more information visit http://www.researchandmarkets.com/research/z3msbh/global_gene |
